Skip to main content
Ritesh International Ltd logo

Ritesh International Ltd — Investor Relations & Filings

Ticker · 519097 ISIN · INE534D01014 LEI · 335800C5M6C2387ZLF47 BSE.NS Manufacturing
Open in API
Filings indexed 451 across all filing types
Latest filing 2025-02-13 Regulatory Filings
Country IN India
Listing BSE.NS 519097

About Ritesh International Ltd

https://www.riteshinternationalltd.com/

Ritesh International Ltd specializes in the manufacturing and distribution of oleochemicals, primarily focusing on stearic acid, fatty acids, and refined glycerine. The company operates processing facilities that utilize high-pressure splitting and vacuum distillation technologies to produce high-purity chemical intermediates. Its product portfolio includes various grades of stearic acid used in the production of rubber, PVC, and textiles, as well as refined glycerine for pharmaceutical and cosmetic applications. The firm serves as a supplier to manufacturers of soaps, detergents, and plastic additives, emphasizing process efficiency and product consistency to meet the technical requirements of diverse industrial sectors.

Recent filings

Filing Released Lang Actions
Integrated Financial for Quarter ended 31.12.2024
Regulatory Filings
2025-02-13 English
In continuation to intimation dated 06.02.2025, we wish to inform you that Board of Directors in its meeting held today the 13th day of February, 2025 the board meeting commenced at 11:00 ....
Regulatory Filings
2025-02-13 English
The Financial Results for 31.12.2024 are attached herewith
Regulatory Filings
2025-02-13 English
RITESH INTERNATIONAL LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2025 ,inter alia, to consider and approve Pursuant to Regulation ....
Board/Management Information Classification · 95% confidence The document is a notice informing about an upcoming Board Meeting scheduled for 13.02.2025. It mentions the agenda to consider and take on record the Un-Audited Financial Results for the quarter ended 31.12.2024 and the Limited Review Report by the Statutory Auditor. The document is an intimation or announcement of the meeting and its agenda, not the actual financial results or reports themselves. The document length is short (1611 characters) and it serves as a notification rather than a full report. Therefore, it fits the category of Board/Management Information (MANG), as it announces a board meeting and related management matters.
2025-02-06 English
Certificate under Regulation 74(5) for Quarter ended 31.12.2024 is attached herewith
Regulatory Filings
2025-01-15 English
Closure of trading window announcement is attached herewith
Regulatory Filings Classification · 95% confidence The document is a notification about the closure of the trading window for insiders and designated persons in compliance with SEBI regulations related to insider trading. It specifies the period during which trading is prohibited due to the upcoming declaration of un-audited financial results for a quarter. The document does not contain any financial data, results, or detailed report content. It is an announcement related to regulatory compliance and trading restrictions rather than a financial report or earnings release. Given its nature as a regulatory compliance announcement, it best fits the category of Regulatory Filings (RNS). The document length is short and it serves as an informational notice rather than a report or detailed filing.
2024-12-28 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.